News

Childhood Leukemia Study Reveals Disease Subtypes, New Treatment


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Childhood Leukemia Study Reveals Disease Subtypes, New Treatment Option


 

Date: 20/03/2015


A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved highly effective in the treatment of lymphomas in adults.

Usually emerging in children between 2 and 5 years of age, ALL occurs when the proliferation of white blood cells known as lymphocytes spirals out of control. The current standard of care for ALL employs high doses of chemotherapy that usually cure the disease, but may also have serious long-term effects on brain development, bone growth and fertility, so there is an unmet need for better therapies.

For more click here.

Source: UCSF

© Catalyst Innovation Portal 2019